Dermatology NewsDupilumab offers ‘clinically meaningful’ improvements in prurigo nodularisSeptember 13, 2022Medical DermatologyAtopic Dermatitis
Can Atopic Dermatitis and Allergic Contact Dermatitis Coexist?September 12, 2022Contact DermatitisAtopic Dermatitis
Dermatology NewsVTE risk not elevated in AD patients on JAK inhibitors: StudyAugust 30, 2022Atopic DermatitisPigmentation DisordersPediatricsMixed Topics
Dermatology NewsAbrocitinib evaluated in patients with and without prior dupilumab treatmentAugust 23, 2022Atopic Dermatitis
Dermatology NewsWhy it’s important for dermatologists to learn about JAK inhibitorsAugust 23, 2022Atopic DermatitisPigmentation DisordersMedical Dermatology
Atopic dermatitis and immune abnormalities in children born to mothers with nickel exposureAugust 22, 2022Atopic Dermatitis
Meta-analysis demonstrates efficacy and safety of IL-13 inhibitors in atopic dermatitis August 22, 2022Atopic Dermatitis
Pseudoceramide+steroid cream rapidly improved skin barrier function in atopic dermatitisAugust 22, 2022Atopic Dermatitis
Dupilumab effective against pruritus in atopic dermatitis in real-life settings August 22, 2022Atopic Dermatitis
Progressive and sustained improvement in atopic dermatitis with tralokinumab plus TCS as needed August 22, 2022Atopic Dermatitis
Patients with controlled atopic dermatitis can opt for dupilumab dose reduction August 22, 2022Atopic Dermatitis
Moderate-to-severe atopic dermatitis: Long-term safety and effectiveness of tralokinumabAugust 22, 2022Atopic Dermatitis
Abrocitinib more promising than dupilumab in moderate-to-severe atopic dermatitisAugust 22, 2022Atopic Dermatitis
